Mpr1 is an enzyme that catalyzes the N-acetylation of the toxic l-azetidine-2-carboxylic acid (AZC). Recently, Mpr1 has been shown to reduce levels of intracellular reactive oxygen species (ROS) under oxidative stress. The natural substrate involved in the ROS elimination in vivo is still unknown. Mpr1 has been purified and crystallized in space groups P1 and P3 1 12. X-ray data were collected to 1.9 Å resolution from a trigonal crystal soaked with AZC.
Introduction
Mpr1 was discovered as an enzyme that is involved in the resistance of Saccharomyces cerevisiae AE1278 to the toxic l-azetidine-2carboxylic acid (AZC), which is a four-membered ring analogue of l-proline. The incorporation of AZC into a protein causes the synthesis of abnormal misfolded proteins and thereby inhibits cell growth. Primary structure analysis of Mpr1 using BLAST suggested that the enzyme was a member of the N-acetyltransferase superfamily, which was supported by the results of site-directed mutagenesis of the acetyl-CoA-binding motif that is highly conserved in the superfamily (Shichiri et al., 2001; Kotani & Takagi, 2008) . Homologues of the N-acetyltransferase specific for AZC acetylation are only present in some yeast strains (Kimura et al., 2002; Nomura et al., 2003; Wada et al., 2008) . AZC, a rare toxic amino acid, only occurs in some plant species such as the Liliaceae family and is unlikely to be a natural substrate of Mpr1 (Leete, 1964; Peterson & Fowden, 1963) . The Mpr1 enzyme may acetylate another substrate in vivo and have a physiologically conserved function in addition to AZC detoxification.
Recently, Mpr1 has been shown to reduce the levels of intracellular reactive oxygen species (ROS) under various types of oxidative stress, including H 2 O 2 , heat shock, freezing and ethanol treatment (Nomura & Takagi, 2004; Du & Takagi, 2005 . Overexpression of Mpr1 leads to an increase in cell viability and a decrease in the ROS level after oxidative treatments, while MPR1 gene-disrupted yeast cells are hypersensitive to oxidative stress. Our attention has been drawn to the l-proline catabolism intermediate Á 1 -pyrroline-5-carboxylate (P5C) and its equilibrium compound glutamate--semialdehyde (GSA), as ROS was detected in a yeast mutant lacking P5C dehydrogenase. In S. cerevisiae, l-proline is converted to l-glutamate within mitochondria by the action of two mitochondrial enzymes: proline oxidase (the PUT1 gene product) and P5C dehydrogenase (the PUT2 gene product). Genetic and enzymatic analyses have shown that Mpr1 probably regulates the ROS level by acetylating P5C or GSA under P5C-induced oxidative stress. Unfortunately, the natural substrate of Mpr1 in the yeast cells has not yet been determined, so that the endogenous role of Mpr1 is still unclear.
There are some other members of the N-acetyltransferase superfamily whose functional properties are not fully understood in vivo: human arylamine N-acetyltransferases (NATs). The NAT enzymes show a relatively broad specificity for heterocyclic amines, including hydrazine drugs and carcinogens (Dalhoff et al., 2005) , and are involved in their detoxification or activation. NATs have genetic polymorphisms that produce enzymes that range from slow to fast acetylators and that have also been associated with individual susceptibilities to various cancers and proposed as a possible biomarker for prostate cancer (Ambrosone & Kadlubar, 1998; Hamasaki et al., 2003; Stacey et al., 1996) . NAT and its orthologues are widely present in both prokaryotes and eukaryotes and the essential catalytic triad Cys-His-Asp has been identified in all known NATs (Grant, 2008; Sim et al., 2008; Westwood et al., 2006; Dupret & Rodrigues-Lima, 2005) . Mpr1 contains only two cysteine residues, which can be replaced by alanine residues without any loss of catalytic activity (data not shown); this mutagenesis result suggested that Mpr1 requires a different catalytic mechanism from NATs as a heterocyclic amine N-acetyltransferase that is involved in resistance towards oxidative stress. In order to reveal the structural fundamentals of substrate recognition and the catalytic mechanism, we have initiated X-ray crystallographic studies of Mpr1.
Materials and methods

Protein expression and purification
The Mpr1 protein was overexpressed according to the method of Shichiri et al. (2001) with slight modification. Competent cells of Escherichia coli strain SG13009 (Qiagen) were transformed with the expression vector pQE2 bearing the gene for full-length Mpr1 with 14 additional N-terminal amino-acid residues (MKHHHHHHMHAG-AQ) in combination with the pRARE plasmid (Novagen) instead of pPREP4. The transformant cells were grown at 303 K in M9 medium containing 2%(w/v) casamino acids, 50 mg ml À1 ampicillin and 34 mg ml À1 chloramphenicol with constant shaking. When the absorbance of the culture at 660 nm reached 0.3, isopropyl -d-1thiogalactopyranoside was added to a final concentration of 0.1 mM and the culture was grown for an additional 18 h at 291 K.
The bacterial cell pellet was resuspended in 50 mM sodium phosphate buffer pH 7.8 and 300 mM NaCl and then disrupted using a Vibra-Cell VCX500 ultrasonic processor (Sonics) at 277 K. The cell lysate was subjected to centrifugation at 20 000g for 20 min to remove the cell debris. The resulting cell-free extract was applied onto an Niaffinity column (His-Trap FF, GE Healthcare Bioscience) equilibrated with 20 mM sodium phosphate buffer pH 7.4, 500 mM NaCl, 10 mM imidazole and the bound protein was eluted using a linear gradient of 10-500 mM imidazole. Fractions containing active Mpr1 were pooled and dialyzed against 50 mM Tris-HCl buffer pH 7.5, 1 mM EDTA, 10 mM imidazole and 10%(w/v) glycerol (buffer A), which was also used to equilibrate an anion-exchange column (DEAE Toyopearl 650M, Tosoh). The applied enzyme passed through the column under isocratic conditions using buffer A and a small amount of concomitant proteins were removed thoroughly. This treatment was an essential step in order to achieve sufficient growth of single crystals. The eluted enzyme was concentrated using an Amicon Ultra-15 ultrafiltration device (10 kDa cutoff). The purified enzyme was analyzed by SDS-PAGE, enzyme-activity assay and DLS. The protein concentration was determined by the method of Bradford (1976) using bovine serum albumin as a standard.
The acetyltransferase activity was assayed at 303 K by monitoring the increase in 5-thio-2-nitrobenzoic acid (TNB) as described previously with slight modification (Shichiri et al., 2001) . The increase in absorbance at 412 nm was measured in the presence of 50 mM H 3 BO 3 /Na 2 B 4 O 7 buffer pH 7.5 instead of ammonium acetate buffer. The reaction rate was calculated using an extinction coefficient for TNB of 15 570 M À1 cm À1 . One unit is defined as the amount of enzyme that catalyzes the formation of 1 mmol TNB per minute at 303 K.
Crystallization and X-ray data collection
For crystallization, the purified protein was concentrated to 1.5-2.0 mg ml À1 by ultrafiltration (Amicon Ultra-500, 10 kDa cutoff, Millipore). Crystals of Mpr1 were grown by the sitting-drop vapourdiffusion technique using a Cryschem crystallization plate (Hampton Research) at a constant temperature of 293 K. 2 ml protein solution was mixed with an equal volume of reservoir solution and the volume of the reservoir solution in the well was 1000 ml.
X-ray diffraction data were collected from the crystal belonging to space group P1 using an ADSC Quantum 4R CCD on synchrotron beamline BL-6A at the Photon Factory, KEK, Japan. The crystal was covered with Paratone-N oil (Hampton Research) and exposed to X-rays at 100 K. Individual frames consisted of a 1 oscillation angle measured for 40 s at a crystal-to-detector distance of 216.1 mm. The P3 1 12 crystals were soaked momentarily in a cryoprotectant solution containing 25% polyethylene glycol (PEG) 400 before cryocooling. In this case, X-ray data were collected using an ADSC Quantum 315 CCD on synchrotron beamline BL-5A and individual frames consisted of a 0.5 oscillation angle measured for 10 s. Intensity data were processed, merged and scaled with MOSFLM and the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) . 
Results and discussion
Mpr1 was overexpressed and purified with a yield of 2 mg protein from 0.5 l culture. The purity of the obtained enzyme was judged to be >95% from SDS-PAGE analysis and DLS analysis gave a monodisperse size distribution (data not shown). Its activity did not change over two weeks at 293 K. Initial screening for Mpr1 crystallization was carried out using the Crystal Screen HT kit (Hampton Research). A number of tiny plate-shaped or needle-shaped crystals were obtained using condition No. 33 (30% PEG 1500). The addition of 25%(w/v) glycerol to the protein solution prevented twinning of the crystals and promoted growth of the crystals up to 200 mm. Optimized crystals were obtained within two weeks at 293 K using reservoir solution containing 20%(w/v) PEG 1500 and 25%(w/v) glycerol. A typical crystal (form I) is shown in Fig. 1(a) . Data from the crystal were recorded to 3.2 Å resolution and were indexed in the triclinic space group P1, with unit-cell parameters a = 84.92, b = 89.93, c = 107.40 Å , = 93.93, = 100.45, = 90.73 . Unfortunately, this triclinic crystal was unsuitable for producing ligand-complex crystals; the presence of ligands (substrates, inhibitors or products) either led to the inhibition of crystal growth or disrupted the crystals.
In order to obtain another crystal form that might be suitable for producing a ligand complex, a second crystallization screening trial was carried out using the Index HT kit (Hampton Research). Prism-shaped crystals (50 mm) were obtained using condition No. 82 [25%(w/v) PEG 3350, 0.1 M bis-tris pH 5.5, 0.2 M MgCl 2 ]. Improved crystals were subsequently obtained within the pH range 5.1-5.5 with 21%(w/v) PEG 3350, 0.1 M bis-tris, 0.2 M MgCl 2 . Crystals appeared after 4 d (1-2 d later than for the form I crystals) and grew to maximum dimensions of 0.16 Â 0.14 Â 0.06 mm within two weeks at 293 K. A typical crystal (form II) is shown in Fig. 1(b) . The crystal used for X-ray analysis was soaked in its reservoir solution containing 25%(w/v) PEG 400 as a cryoprotectant and then flash-cooled in a cold nitrogen stream at 100 K. Data for the crystal were collected to a resolution of 2.5 Å at a crystal-to-detector distance of 250 mm. Analysis of merging statistics and systematic absences indicated that the crystals belonged to space group P3 1 12, with unit-cell parameters a = b = 84.06, c = 192.34 Å . Cumulative intensity distributions indicated no twinning. In contrast to the triclinic crystals, soaking crystal form II in reservoir solution containing 50 mM AZC and 25%(w/v) PEG 400 for 1 min at 293 K led to a notable improvement in the diffraction quality of the crystal without a significant change in the unit cell. Data were collected from the AZC-soaked crystal to a resolution of 1.9 Å at a crystal-to-detector distance of 237.8 mm (Fig. 2) . This crystal also belonged to space group P3 1 12, with unitcell parameters a = b = 83.87, c = 193.82 Å . Estimation of the content of the asymmetric unit based on a single Mpr1 subunit gave a Matthews coefficient V M of 2.36 Å 3 Da À1 (Matthews, 1968) , corresponding to 47.9% solvent content. Data-collection and processing statistics are shown in Table 1 .
Structure determination was attempted using the molecularreplacement method as implemented in the program Phaser (McCoy et al., 2007) , but no solution could be found that correctly placed the template molecules in the crystal unit cells. The failure of molecular replacement is probably a result of the low degree (<15%) of sequence identity between Mpr1 and the search models of other acetyltransferases. A search for heavy-atom derivatives for use in the multi-wavelength anomalous diffraction method is now under way. Diffraction image obtained on Photon Factory beamline BL-5A. Diffraction data were collected at a wavelength of 0.9793 Å with a crystal-to-detector distance of 237.8 mm. The resolution at the edges of the image is 1.9 Å . 
